The US Preventive Services Task Force (USPSTF), an influential panel whose recommendations often have widespread implications, recently made a new recommendation about screening healthy men for prostate cancer. They now recommend against using the PSA test to screen for prostate cancer in healthy men of any age.
The USPSTF had previously recommended against screening men aged 75 or over for prostate cancer. The recommendation now extends to all healthy men regardless of age.
The panel's recommendation was published recently in the Annals of Internal Medicine. The panel's members stated that they could not find enough scientific evidence documenting reduced prostate cancer mortality from widespread prostate cancer screening.
They also said that they found much evidence of adverse consequences arising from widespread screening - such as unnecessary prostate biopsies or the detection and treatment of cancers which would never have resulted in death or significant problems.
The panel's recommendations have already been met with fierce criticism from a number of groups including the American Urological Association and many prominent prostate cancer physicians.
Undoubtedly, there is much more to come regarding this controversial recommendation.